Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United Kingdom.

The Journal of infection·2026

Same author

Randomized, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy Adults.

Journal of clinical pharmacology·2026

Same author

Advances in the Drug Discovery and Development Pipeline and Emerging Drug Targets.

Cold Spring Harbor perspectives in medicine·2026

Same author

Rising bedaquiline resistance: exploring potential causes and next steps.

The European respiratory journal·2026

Same author

Combined Oral Contraceptive Drug-Drug Interaction Study With Ganfeborole, a New Anti-Tuberculosis Agent.

Journal of clinical pharmacology·2026

Same author

Revival of Ethionamide by Alpibectir.

The New England journal of medicine·2026

Search research articles

Related Experiment Video

Updated: May 17, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis a re-emerging disease.

Saverio De Lorenzo¹, Simon Tiberi

¹Department of Phthisiology and Pulmonology, Morelli Hospital, AOVV, via E.Zubiani 33, 23035, Sondalo (SO), Italy. sfdelore@virgilio.it

Internal and Emergency Medicine

|October 18, 2012

Summary

This summary is machine-generated.

Tuberculosis (TB) is a growing concern in Italy, with foreign-born cases now exceeding native ones. Increased multi-drug resistant TB and new risk groups necessitate enhanced screening and training for doctors.

Related Experiment Videos

Last Updated: May 17, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

Public Health
Infectious Diseases
Epidemiology

Background:

Tuberculosis (TB) affects nearly one-third of the global population.
In Italy, foreign-born TB cases surpassed native cases in 2008.
Elderly native Italians are a vulnerable group, often experiencing delayed TB diagnosis due to low clinical suspicion.

Purpose of the Study:

To highlight the changing epidemiology of TB in Italy.
To address challenges in diagnosing and treating TB in specific populations.
To emphasize the need for improved screening and medical education regarding TB.

Main Methods:

Analysis of TB case trends in Italy, differentiating between native and foreign-born individuals.
Review of diagnostic challenges in elderly populations.
Assessment of the impact of TNF inhibitors and immigration on TB incidence and resistance patterns.

Main Results:

Foreign-born TB cases now outnumber native cases in Italy.
Immigration from high-incidence countries increases multi-drug resistant TB.
Use of TNF inhibitors creates a new at-risk population for severe TB.

Conclusions:

There is an urgent need for enhanced TB screening protocols.
Medical education must adapt to the evolving TB landscape, particularly for young doctors.
Addressing socioeconomic factors is crucial for managing complex TB cases.